Role of the sugar moiety in the pharmacological activity of anthracyclines: Development of a novel series of disaccharide analogs

Biochemical Pharmacology

Volumn 61, Issue 8, 2001, Pages 933-938

  Zunino, Franco ^a   Pratesi, Graziella ^a   Perego, Paola ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Anthracyclines; Antitumor therapy; Disaccharides

Indexed keywords

ANTHRACYCLINE; CARBOHYDRATE DERIVATIVE; DNA TOPOISOMERASE; IDARUBICIN DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0035871958     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00522-6     Document Type: Article

References (37)

1. The anthracyclines: Will we ever find a better doxorubicin?
2. DNA topoisomerases: Essential enzymes and lethal targets
3. DNA topoisomerase II as the primary target of anti-tumor anthracyclines
4. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: Influence of stereochemistry and conformation
5. Influence of structural modifications at the 3′ and 4′ positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance
6. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells
7. Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety
8. Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharides
9. Topoisomerase poisoning activity of novel disaccharide anthracyclines
10. Doxorubicin disaccharide analogue: Apoptosis-related improvement of efficacy in vivo
11. Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts
12. Relationship between activity and amino sugar sterochemistry of daunorubicin and adriamycin derivatives
13. Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction of removal of hydroxyl groups in the amino sugar moiety
14. The interaction of adriamycin and its β anomer with DNA
15. Doxorubicin
16. Interaction of daunomycin and its derivatives with DNA
17. Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity
18. Sequence-specific DNA interactions by novel alkylating anthracycline derivatives
19. A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons
20. Structural comparison of anticancer drug-DNA complexes: Adriamycin and daunomycin
21. Antitumor inhibitors of DNA topoisomerases
22. Sequence-selective groove binders
23. Biosynthetic anthracyclines
24. New developments in antitumor anthracyclines
25. Synthesis and antitumor activity of anthracycline disaccharide glycosides containing daunosamine
26. Human DNA topoisomerase IIα-dependent DNA cleavage and yeast cell killing by anthracycline analogues
27. Molecular pharmacology of anthracycline antitumor antibiotics
28. Aclacinomycin A stabilizes topoisomerase I covalent complexes
29. Structure by NMR of antitumor drugs aclacinomycin A and B complexed to d(CGTACG)
30. Enzymatic and chemical footprinting of anthracycline antitumor antibiotics and related saccharide side chains
31. Differential poisoning of topoisomerases by menogaryl and nogalamycin dictated by the minor groove-binding nogalose sugar
32. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerase I and II
33. New anthracycline disaccharides. Synthesis of l-daunosaminyl-α(1→4)-2-deoxy-l-rhamnosyl and l-daunosaminyl-α-(1→4)-2-deoxy-l-fucosyl daunorubicin analogues [Perkin I]
34. Conformational analysis of 4-demethoxy-7-O-[2,6-dideoxy-4-O-(2,3,6-trideoxy-3-amino-α-l-lyxo- hexopyranosyl)-α-l-lyxo-hexopyranosyl] adriamycinone, the first doxorubicin disaccharide analogue to be reported
35. Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines
36. Bcl-2 phosphorylation in a human breast carcinoma xenograft: A common event in response to effective DNA-damaging drugs
37. Tissue distribution, antitumor activity and in vivo apoptosis induction by MEN10755 in nude mice